Lentinus Edodes Mycelia Polysacharide Tablets Application Scope

Mycelia Polysacharide Tablets are mainly used as an adjuvant to cancer chemotherapy and in conjunction with the treatment of malignant tumors. Especially in Japan and China, it is commonly used to improve the function of the immune system.

lentinus edodes mycelia polysacharide tablets

Lentinus Edodes Mycelia Polysacharide Tablets Characteristics

Ingredients: The main ingredient is mannan peptide, which is the combination of a-bonded mannose and peptide, and its polysaccharide part is mainly mannose, followed by galactose, glucose, xylose and fucose, with the ratio of 74:12:12:1:1, The peptide chain, on the other hand, consists of aspartic acid． Serine, lysine, glutamic acid and other 18 L-type amino acids.

Characteristics: yellow film-coated tablets

Specification: 10mg

Packing: 10mg*12T

Storage: sealed

Expiry date: 24 months

Execution Standard: WS1-XG-027-2002

Approval number: State Drug License H42022609

Revision date: March 28, 2012

Manufacturer: Wuhan Dior Pharmaceutical Co.

Guidelines For The Use Of Lentinus Edodes Mycelia Polysacharide Tablets

Usage and dosage: Take orally, 1-2 tablets twice daily or as directed by a physician; take after meals.

Adverse Reactions: No specific adverse reactions have been identified.

Medication Limitations

Contraindications: No specific adverse reactions have been identified.

Precautions: It is an immune-enhancing agent that can only increase depressed immune function, not normal immune function. Efficacy is not proportional to dose, but only within the prescribed dose range.

Lentinus Edodes Mycelia Polysacharide Tablets Interactions

Drug interactions: Not known.

Note:

If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from HongKong DengYue Medicine. It is only for internal discussion among medical staff and does not serve as a basis for medication. For specific medication guidelines, please consult the attending physician.